Diagnostic and prognostic value of incidence of K-ras codon 12 mutations in resected distal bile duct carcinoma

Journal of Surgical Oncology

Volumn 68, Issue 3, 1998, Pages 187-192

  Rijken, Arjen M ^a   Van Gulik, Thomas M ^a   Polak, Mirjam M ^a   Sturm, Patrick D J ^a   Gouma, Dirk J ^a   Offerhaus, G Johan A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Biliary cancer; Biliary surgery; K ras; Oncogenes; Polymerase chain reaction (PCR)

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; CODON; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; INCIDENCE; MALE; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; CODON; FEMALE; GENES, RAS; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; PROGNOSIS; SURVIVAL RATE;

EID: 0031852049     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199807)68:3<187::AID-JSO11>3.0.CO;2-Z     Document Type: Article

References (28)

1. Anonymous: American Joint Committee on Cancer. Extrahepatic bile ducts (exclusive of ampulla and intrapancreatic bile duct). In American Joint Committee on Cancer (ed): "Manual for Staging of Cancer," 2nd ed. Philadelphia: Lippincott, 1983;91-94.
2. Longmire WP, Mc Arthur MS, Bastounis EA, Hiatt J: Carcinoma of the extrahepatic biliary tract. Ann Surg 1973;178:333-345.
3. Hruban RH, van Mansfield AD, Offerhaus GJ, et al.: K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993;143:545-554.
4. Lemoine NR, Jain S, Hughes CM, et al: Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 1992;102: 230-236.
5. Capella G, Cronauer-Mitra S, Pienado MA. Perucho M: Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors. Environ Health Perspect 1991;93: 125-131.
6. Almoguera C, Shibata D, Forrester K, et al.: Most human carcinomas of the exocrine pancreas contain mutant c-K-ras gene. Cell 1988;53:549-554.
7. Tada M, Ohashi M, Shiratori Y, et al.: Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 1996;110:227-231.
8. Motojima K, Tsunoda T, Kanematsu T, et al.: Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene. Ann Surg 1991;214: 657-662.
9. Tada M, Yokosuka O, Omata M, et al.: Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing. Cancer 1990;66:930-935.
10. Albores-Saavedra J. Henson DE, Sobin LH: The WHO histological classification of tumors of the gallbladder and extrahepatic bile ducts. A commentary on the second edition. Cancer 1992;70:410-414.
11. Slebos RJ, Boerrigter L, Evers SG, et al.: A rapid and simple procedure for the routine detection of ras point mutations in formalin-fixed, paraffin-embedded tissues. Diagn Mol Pathol 1992; 1:136-141.
12. Caldas C, Hahn SA, Hruban RH, et al.: Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 1994;54:3568-3573.
13. Satoh K, Sawai T, Shimosegawa T, et al.: The point mutation of c-Ki-ras at codon 12 in carcinoma of the pancreatic head region and in intraductal mucin-hypersecreting neoplasm of the pancreas. Int J Pancreatol 1993;14:135-143.
14. Levi S, Urbano-Ispizua A, Gill R, et al.: Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991;51:3497-3502.
15. Slebos RJ, Kibbelaar RE, Dalesio O, et al.: K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 1990;323:561-565.
16. Smith EF, Groen HJ, Splinter TA, et al.: New prognostic factor in resectable non-small cell lung cancer. Thorax 1996;51:638-646.
17. Allema JH, Reinders ME, van Gulik TM, et al.: Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer 1995;75:2069-2076.
18. Watanabe M, Asaka M, Tanaka J, et al.: Point mutations of K-ras gene codon 12 in biliary tract tumors. Gastroenterology 1994;107: 1147-1153.
19. Longnecker DS, Terhune PG: The case for parallel classification of biliary tract and pancreatic neoplasms. Mol Pathol 1996;9:828-837.
20. Imai M, Hoshi T, Ogawa K: K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis. Cancer 1994;73:2727-2733.
21. Stork P, Loda M, Bosari S, et al.: Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction. Oncogene 1991;6:857-862.
22. Langer JC, Langer B, Taylor BR, et al.: Carcinoma of the extrahepatic bile ducts: Results of an aggressive surgical approach. Surgery 1985;98:752-759.
23. Nakeeb A, Pitt HA, Sohn TA, et al.: Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996;224:463-473.
24. Klempnauer J, Ridder GJ, Bektas H, Pichlmayr R: Surgery for exocrine pancreatic cancer - who are the 5- and 10-year survivors? Oncology 1995;52:353-359.
25. Hurwitz M, Sawicki M, Samara G, Passaro E, Jr.: Diagnostic and prognostic molecular markers in cancer. Am J Surg 1992; 164: 299-306.
26. Scarpa A, Zamboni G, Achille A, et al.: ras-family gene mutations in neoplasia of the ampulla of Vater. Int J Cancer 1994;59:39-42.
27. Vogelstein B, Fearon ER, Hamilton SR, et al.: Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319: 525-532.
28. Marx J: Many gene changes found in cancer. Science 1989;246: 1386-1388.